• |
  • |
  • |
  • |
Donate

Project

NFX-179-NF1-202

Center:
Fiscal Year:
2024
Contact Information:
Project Description:
Title: NFX-179-NF1-202: A randomized, double-blind, vehicle-controlled, parallel group phase 2 dose-response study to determine safety and effectiveness of two concentrations of NFX-179 gel in subjects with cutaneous neurofibromas Role: Site PI Funding: Nflexion Therapeutics 2022-present Summary: This is a randomized, double blind, placebo-controlled study to determine the safety and efficacy of 2 concentrations of NFX-179 gel in subjects with NF1 for treatment of cutaneous neurofibromas.
Keyword(s):
Core Function(s):
Performing Research or Evaluation, Continuing Education/Community Training
Area of Emphasis
Other
Target Audience:
Children/Adolescents with Disabilities/SHCN
Unserved or Under-served Populations:
Specific Groups
Primary Target Audience Geographic Descriptor:
National
Funding Source:
COVID-19 Related Data:
N/A